BIOMAT Database Logo BIOMAT Database Logo

Lymphocyte subsets in HIV-exposed uninfected infants and HIV-unexposed uninfected infants. 2017

Yanling Huo, and Kunjal Patel, and Gwendolyn B Scott, and Russell B Van Dyke, and George K Siberry, and Sandra K Burchett, and William T Shearer
Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Mass. Electronic address: yhuo@sdac.harvard.edu.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016130 Immunophenotyping Process of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry. Lymphocyte Immunophenotyping,Lymphocyte Subtyping,Immunologic Subtyping,Immunologic Subtypings,Lymphocyte Phenotyping,Subtyping, Immunologic,Subtypings, Immunologic,Immunophenotyping, Lymphocyte,Immunophenotypings,Immunophenotypings, Lymphocyte,Lymphocyte Immunophenotypings,Lymphocyte Phenotypings,Lymphocyte Subtypings,Phenotyping, Lymphocyte,Phenotypings, Lymphocyte,Subtyping, Lymphocyte,Subtypings, Lymphocyte

Related Publications

Yanling Huo, and Kunjal Patel, and Gwendolyn B Scott, and Russell B Van Dyke, and George K Siberry, and Sandra K Burchett, and William T Shearer
Lymphocyte Subsets in HIV-Exposed Uninfected Infants: The Impact of Neonatal Postexposure Prophylaxis With Zidovudine.
April 2020, Open forum infectious diseases,
Yanling Huo, and Kunjal Patel, and Gwendolyn B Scott, and Russell B Van Dyke, and George K Siberry, and Sandra K Burchett, and William T Shearer
HIV-Exposed, Uninfected Infants in Uganda Experience Poorer Growth and Body Composition Trajectories than HIV-Unexposed Infants.
October 2020, Journal of acquired immune deficiency syndromes (1999),
Yanling Huo, and Kunjal Patel, and Gwendolyn B Scott, and Russell B Van Dyke, and George K Siberry, and Sandra K Burchett, and William T Shearer
A Meta-analysis Assessing Diarrhea and Pneumonia in HIV-Exposed Uninfected Compared With HIV-Unexposed Uninfected Infants and Children.
September 2019, Journal of acquired immune deficiency syndromes (1999),
Yanling Huo, and Kunjal Patel, and Gwendolyn B Scott, and Russell B Van Dyke, and George K Siberry, and Sandra K Burchett, and William T Shearer
A meta-analysis assessing all-cause mortality in HIV-exposed uninfected compared with HIV-unexposed uninfected infants and children.
September 2016, AIDS (London, England),
Yanling Huo, and Kunjal Patel, and Gwendolyn B Scott, and Russell B Van Dyke, and George K Siberry, and Sandra K Burchett, and William T Shearer
A Meta-analysis Assessing Diarrhea and Pneumonia in HIV-Exposed Uninfected Compared With HIV-Unexposed Uninfected Infants and Children: Erratum.
February 2020, Journal of acquired immune deficiency syndromes (1999),
Yanling Huo, and Kunjal Patel, and Gwendolyn B Scott, and Russell B Van Dyke, and George K Siberry, and Sandra K Burchett, and William T Shearer
Increased infectious-cause hospitalization among infants who are HIV-exposed uninfected compared with HIV-unexposed.
November 2021, AIDS (London, England),
Yanling Huo, and Kunjal Patel, and Gwendolyn B Scott, and Russell B Van Dyke, and George K Siberry, and Sandra K Burchett, and William T Shearer
Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency.
May 2014, BMC infectious diseases,
Yanling Huo, and Kunjal Patel, and Gwendolyn B Scott, and Russell B Van Dyke, and George K Siberry, and Sandra K Burchett, and William T Shearer
Higher prevalence of stunting and poor growth outcomes in HIV-exposed uninfected than HIV-unexposed infants in Kenya.
March 2022, AIDS (London, England),
Yanling Huo, and Kunjal Patel, and Gwendolyn B Scott, and Russell B Van Dyke, and George K Siberry, and Sandra K Burchett, and William T Shearer
Neurodevelopment of HIV-Exposed and HIV-Unexposed Uninfected Children at 24 Months.
October 2017, Pediatrics,
Yanling Huo, and Kunjal Patel, and Gwendolyn B Scott, and Russell B Van Dyke, and George K Siberry, and Sandra K Burchett, and William T Shearer
A Prospective Cohort Study of Common Childhood Infections in South African HIV-exposed Uninfected and HIV-unexposed Infants.
February 2017, The Pediatric infectious disease journal,
Copied contents to your clipboard!